36940-87-1 Usage
Uses
Used in Research Applications:
2'-O-Monosuccinyladenosine 3':5'-Cyclic Monophosphate is used as a research tool for studying the role of cAMP in cellular processes. It helps researchers understand the mechanisms of signal transduction and the regulation of various cellular functions.
Used in Pharmaceutical Development:
In the pharmaceutical industry, 2'-O-Monosuccinyladenosine 3':5'-Cyclic Monophosphate is used as a starting material for the development of new drugs targeting cAMP-mediated pathways. Its unique properties make it a promising candidate for the creation of novel therapeutic agents.
Used in Diagnostic Applications:
2'-O-Monosuccinyladenosine 3':5'-Cyclic Monophosphate is used as a diagnostic agent for the detection and measurement of cAMP levels in biological samples. This helps in the identification of various diseases and conditions related to the dysregulation of cAMP signaling.
Used in Immunological Applications:
In the field of immunology, 2'-O-Monosuccinyladenosine 3':5'-Cyclic Monophosphate is used to generate anti-cAMP antisera and antibodies. These antibodies can be employed in various immunoassays, such as enzyme-linked immunosorbent assays (ELISA), to detect and quantify cAMP in biological samples.
Used in Drug Delivery Systems:
Similar to gallotannin, 2'-O-Monosuccinyladenosine 3':5'-Cyclic Monophosphate can also be incorporated into drug delivery systems to enhance its bioavailability and therapeutic outcomes. This may involve the use of nanoparticles or other carriers to improve the delivery of this cAMP analog to target cells and tissues.
Check Digit Verification of cas no
The CAS Registry Mumber 36940-87-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,6,9,4 and 0 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 36940-87:
(7*3)+(6*6)+(5*9)+(4*4)+(3*0)+(2*8)+(1*7)=141
141 % 10 = 1
So 36940-87-1 is a valid CAS Registry Number.